CVS HEALTH Corp
Financial highlights
| Metric | FY December 31, 2025 | FY December 31, 2024 | FY December 31, 2023 | FY December 31, 2022 | FY December 31, 2021 |
|---|---|---|---|---|---|
| Revenue | $402.1B | $372.8B | $357.8B | $322.5B | $292.1B |
| Operating income | $4.7B | $8.5B | $13.7B | $8.0B | $13.3B |
| Cost of revenue | $221.2B | $206.3B | $217.1B | $196.9B | $175.8B |
| Cash from operations | $10.6B | $9.1B | $13.4B | $16.2B | $18.3B |
| Capital expenditure | $2.8B | $2.8B | $3.0B | $2.7B | $2.5B |
| Free cash flow | $7.8B | $6.3B | $10.4B | $13.4B | $15.7B |
| Share repurchases | $0 | $3.0B | $2.0B | $3.5B | $0 |
| Impairments | $5.7B | $0 | $152.0M | $0 | $431.0M |
| Total assets | $253.5B | $253.2B | $249.7B | $228.3B | $233.0B |
| Total liabilities | $178.2B | $177.5B | $173.1B | $156.5B | $157.6B |
| Total debt | $63.7B | $63.3B | $60.6B | $51.3B | $55.4B |
Shares outstanding 1.3B · Free float 96.3%
Annual filing data through FY ended December 31, 2025; float as of July 8, 2026.